BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301) ; volume:15 ; number:1 ; day:27 ; month:5 ; year:2015 ; pages:1-7 ; date:12.2015
BMC cancer ; 15, Heft 1 (27.5.2015), 1-7, 12.2015
- Urheber
-
Hayne, Dickon
- Beteiligte Personen und Organisationen
-
Stockler, Martin
McCombie, Steve P.
Chalasani, Venu
Long, Anne
Martin, Andrew
Sengupta, Shomik
Davis, Ian D.
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1431-6
- URN
-
urn:nbn:de:1111-2016110616488
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hayne, Dickon
- Stockler, Martin
- McCombie, Steve P.
- Chalasani, Venu
- Long, Anne
- Martin, Andrew
- Sengupta, Shomik
- Davis, Ian D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Protective role of intravesical BCG in COVID-19 severity
A solitary pulmonary nodule caused by Mycobacterium tuberculosis var. BCG after intravesical BCG treatment: a case report
Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?
Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
Bacille Calmette-Guérin (BCG) spondylitis with adjacent mycotic aortic aneurysm after intravesical BCG therapy: a case report and literature review
B.C.G.-Schutzimpfung
B.C.G.-Schutzimpfung
BCG-Lupus
BCG-Schutzimpfung
Mycotic aortic aneurysms post-Intravesical BCG treatment for early-stage bladder carcinoma
High-Risk Non-Muscle-Invasive Bladder Cancer—Therapy Options During Intravesical BCG Shortage
Protective role of intravesical BCG in COVID-19 severity
A solitary pulmonary nodule caused by Mycobacterium tuberculosis var. BCG after intravesical BCG treatment: a case report
Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?
Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
Bacille Calmette-Guérin (BCG) spondylitis with adjacent mycotic aortic aneurysm after intravesical BCG therapy: a case report and literature review
B.C.G.-Schutzimpfung
B.C.G.-Schutzimpfung
BCG-Lupus
BCG-Schutzimpfung
Mycotic aortic aneurysms post-Intravesical BCG treatment for early-stage bladder carcinoma
High-Risk Non-Muscle-Invasive Bladder Cancer—Therapy Options During Intravesical BCG Shortage
Protective role of intravesical BCG in COVID-19 severity
A solitary pulmonary nodule caused by Mycobacterium tuberculosis var. BCG after intravesical BCG treatment: a case report
Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?
Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
Bacille Calmette-Guérin (BCG) spondylitis with adjacent mycotic aortic aneurysm after intravesical BCG therapy: a case report and literature review
B.C.G.-Schutzimpfung
B.C.G.-Schutzimpfung
BCG-Lupus
BCG-Schutzimpfung
Mycotic aortic aneurysms post-Intravesical BCG treatment for early-stage bladder carcinoma